Allworth Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $522K | Buy |
994
+173
| +21% | +$90.9K | ﹤0.01% | 829 |
|
|
2025
Q1 | $493K | Sell |
821
-137
| -14% | -$82.2K | ﹤0.01% | 683 |
|
|
2024
Q4 | $651K | Buy |
958
+249
| +35% | +$169K | ﹤0.01% | 623 |
|
|
2024
Q3 | $745K | Buy |
709
+48
| +7% | +$50.4K | ﹤0.01% | 492 |
|
|
2024
Q2 | $703K | Buy |
661
+133
| +25% | +$141K | ﹤0.01% | 491 |
|
|
2024
Q1 | $508K | Buy |
528
+166
| +46% | +$160K | ﹤0.01% | 542 |
|
|
2023
Q4 | $318K | Buy |
362
+4
| +1% | +$3.51K | ﹤0.01% | 629 |
|
|
2023
Q3 | $295K | Buy |
358
+16
| +5% | +$13.2K | ﹤0.01% | 608 |
|
|
2023
Q2 | $246K | Buy |
342
+179
| +110% | +$129K | ﹤0.01% | 646 |
|
|
2023
Q1 | $134K | Buy |
163
+24
| +17% | +$19.7K | ﹤0.01% | 756 |
|
|
2022
Q4 | $100K | Buy |
139
+10
| +8% | +$7.22K | ﹤0.01% | 815 |
|
|
2022
Q3 | $89K | Buy |
129
+37
| +40% | +$25.5K | ﹤0.01% | 800 |
|
|
2022
Q2 | $54K | Buy |
92
+45
| +96% | +$26.4K | ﹤0.01% | 881 |
|
|
2022
Q1 | $33K | Sell |
47
-8
| -15% | -$5.62K | ﹤0.01% | 1042 |
|
|
2021
Q4 | $35K | Buy |
55
+23
| +72% | +$14.6K | ﹤0.01% | 936 |
|
|
2021
Q3 | $19K | Buy |
+32
| New | +$19K | ﹤0.01% | 1061 |
|
|
2021
Q2 | – | Sell |
-36
| Closed | -$17K | – | 1646 |
|
|
2021
Q1 | $17K | Hold |
36
| – | – | ﹤0.01% | 837 |
|
|
2020
Q4 | $17K | Hold |
36
| – | – | ﹤0.01% | 710 |
|
|
2020
Q3 | $20K | Hold |
36
| – | – | ﹤0.01% | 570 |
|
|
2020
Q2 | $22K | Buy |
+36
| New | +$22K | ﹤0.01% | 572 |
|
|
2017
Q2 | – | Sell |
-4
| Closed | -$2K | – | 816 |
|
|
2017
Q1 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 660 |
|